In 2011, the transmembrane glycoprotein CD44, a cancer stem-like cell marker, and more precisely the CD44 variant (CD44 v ) capable to bind hyaluronan has also been described to interacts and stabilizes system (Figure 1)
Still others may have comorbid metabolic issues such as metabolic syndrome or PCOS, which will make them especially sensitive to carbohydrates due to the early stages of insulin resistance
Patients asking about it should be told the trial data are real, the drug is on a credible path to FDA review, and the right move is to wait, not to source it through grey channels
Based on the available research, the answer appears to be yes
Outcome selection The primary outcomes were overall ovarian cancer and its five major histological subtypes: high-grade serous (HGSOC), low-grade serous (LGSOC), endometrioid (ENOC), mucinous (MOC), and clear cell (CCOC) carcinoma